Subtle microstructural changes of the cerebellum in a knock-in mouse model of DYT1 dystonia

Neurobiology of Disease

Volumn 62, Issue , 2014, Pages 372-380

  Song, Chang Hyun ^a,b   Bernhard, Doug ^a   Hess, Ellen J ^a   Jinnah, H A ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Daegu Haany University   (South Korea)

Author keywords

Anatomy; Cerebellum; Deep cerebellar neuron; Golgi histochemistry; Heterotopic cells; Mouse mutant; Purkinje cells; Stereology

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; CELL COUNT; CEREBELLUM DISEASE; CEREBELLUM NUCLEUS; CONTROLLED STUDY; DENDRITIC SPINE; DISEASE MODEL; DYSTONIA; DYT1 DYSTONIA; FEMALE; GOLGI COMPLEX; GRANULE CELL; HISTOCHEMISTRY; MALE; MOUSE; MOUSE MUTANT; NONHUMAN; PRIORITY JOURNAL; PURKINJE CELL; STEREOLOGY;

ANATOMY; AP; CEREBELLUM; DCN; DEEP CEREBELLAR NEURON; DEEP CEREBELLAR NUCLEI; DELETION OF A SINGLE GAG CODON IN TOR1A GENE; GC; GCL; GOLGI HISTOCHEMISTRY; GRANULE CELL; GRANULE CELL LAYER; HETEROTOPIC CELLS; MCL; MOLECULAR CELL LAYER; MOUSE MUTANT; PC; PURKINJE CELL; PURKINJE CELLS; REGION FROM BREGMA IN THE ANTERIOR-POSTERIOR DIRECTION; STEREOLOGY; WHITE MATTER; WM; ΔE;

ANIMALS; CELL COUNT; CEREBELLUM; DENDRITIC SPINES; DISEASE MODELS, ANIMAL; DYSTONIA; FEMALE; GENE KNOCK-IN TECHNIQUES; MALE; MICE; MICE, INBRED C57BL; MOLECULAR CHAPERONES; PURKINJE CELLS;

EID: 84887545267     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2013.10.003     Document Type: Article

References (71)

1. Albanese A., et al. Phenomenology and classification of dystonia: a consensus update. Mov. Disord. 2013, 28:863-873.
2. Alvarez-Fischer D., et al. Prolonged generalized dystonia after chronic cerebellar application of kainic acid. Brain Res. 2012, 1464:82-88.
3. Argyelan M., et al. Cerebellothalamocortical connectivity regulates penetrance in dystonia. J. Neurosci. 2009, 29:9740-9747.
4. Augood S.J., et al. Distribution of the mRNAs encoding torsinA and torsinB in the normal adult human brain. Ann. Neurol. 1999, 46:761-769.
5. Avanzino L., Abbruzzese G. How does the cerebellum contribute to the pathophysiology of dystonia. Basal Ganglia 2012, 2:231-235.
6. Bonhoeffer T., Yuste R. Spine motility: phenomenology, mechanisms, and function. Neuron 2002, 35:1019-1027.
7. Calabresi P., et al. Endogenous adenosine mediates the presynaptic inhibition induced by aglycemia at corticostriatal synapses. J. Neurosci. 1997, 17:4509-4516.
8. Campbell D.B., et al. Tottering mouse motor dysfunction is abolished on the Purkinje cell degeneration (pcd) mutant background. Exp. Neurol. 1999, 160:268-278.
9. Carbon M., et al. Regional metabolism in primary torsion dystonia: effects of penetrance and genotype. Neurology 2004, 62:1384-1390.
10. Carbon M., et al. Increased cerebellar activation during sequence learning in DYT1 carriers: an equiperformance study. Brain 2008, 131:146-154.
11. Carbon M., et al. Increased sensorimotor network activity in DYT1 dystonia: a functional imaging study. Brain 2010, 133:690-700.
12. Centonze D., et al. Distinct roles of D1 and D5 dopamine receptors in motor activity and striatal synaptic plasticity. J. Neurosci. 2003, 23:8506-8512.
13. Chen G., et al. Low-frequency oscillations in the cerebellar cortex of the tottering mouse. J. Neurophysiol. 2009, 101:234-245.
14. Dang M.T., et al. Generation and characterization of Dyt1 deltaGAG knock-in mouse as a model for early-onset dystonia. Exp. Neurol. 2005, 196:452-463.
15. 15O PET study. Brain 2004, 127:1899-1908.
16. Draganski B., et al. Genotype-phenotype interactions in primary dystonias revealed by differential changes in brain structure. Neuroimage 2009, 47:1141-1147.
17. Eidelberg D., et al. Functional brain networks in DYT1 dystonia. Ann. Neurol. 1998, 44:303-312.
18. Fan X., et al. Selective and sustained alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor activation in cerebellum induces dystonia in mice. J. Pharmacol. Exp. Ther. 2012, 340:733-741.
19. Fiala J.C., et al. Dendritic spine pathology: cause or consequence of neurological disorders. Brain Res. Rev. 2002, 39:29-54.
20. Filip P., et al. Dystonia and the cerebellum: a new field of interest in movement disorders?. Clin. Neurophysiol. 2013, 124:1269-1274.
21. Fung V.S., et al. Assessment of the patient with dystonia: an update on dystonia syndromes. Mov. Disord. 2013, 28:889-898.
22. Gomez C.M., et al. Spinocerebellar ataxia type 6: gaze-evoked and vertical nystagmus, Purkinje cell degeneration, and variable age of onset. Ann. Neurol. 1997, 42:933-950.
23. Goodchild R.E., et al. Loss of the dystonia-associated protein torsinA selectively disrupts the neuronal nuclear envelope. Neuron 2005, 48:923-932.
24. Granata A., et al. TorsinA and dystonia: from nuclear envelope to synapse. J. Neurochem. 2009, 109:1596-1609.
25. Grundmann M., et al. Overexpression of human wildtype torsinA and human deltaGAG torsinA in a transgenic mouse model causes phenotypic abnormalities. Neurobiol. Dis. 2007, 27:190-206.
26. Grundmann K., et al. Generation of a novel rodent model for DYT1 dystonia. Neurobiol. Dis. 2012, 47:61-74.
27. Hallett M. Pathophysiology of dystonia. J. Neural Transm. Suppl. 2006, 70:485-488.
28. Hewett J.W., et al. Dystonia-causing mutant torsinA inhibits cell adhesion and neurite extension through interference with cytoskeletal dynamics. Neurobiol. Dis. 2006, 22:98-111.
29. Konakova M., Pulst S.M. Immunocytochemical characterization of torsin proteins in mouse brain. Brain Res. 2001, 922:1-8.
30. Konakova M., et al. Cellular distribution of torsin A and torsin B in normal human brain. Arch. Neurol. 2001, 58:921-927.
31. Kuo S.H., et al. Increased number of heterotopic Purkinje cells in essential tremor. J. Neurol. Neurosurg. Psychiatry 2011, 82:1038-1040.
32. LeDoux M.S., et al. Cerebellectomy eliminates the motor syndrome of the genetically dystonic rat. Exp. Neurol. 1993, 120:302-310.
33. LeDoux M.S., et al. Selective elimination of cerebellar output in the genetically dystonic rat. Brain Res. 1995, 697:91-103.
34. LeDoux M.S., et al. Single-unit activity of cerebellar nuclear cells in the awake genetically dystonic rat. Neuroscience 1998, 86:533-545.
35. Martella G., et al. Impairment of bidirectional synaptic plasticity in the striatum of a mouse model of DYT1 dystonia: role of endogenous acetylcholine. Brain 2009, 132:2336-2349.
36. McCarthy D.M., et al. Neurogenesis and neuronal migration in the forebrain of the TorsinA knockout mouse embryo. Dev. Neurosci. 2012, 34:366-378.
37. McNaught K.S., et al. Brainstem pathology in DYT1 primary torsion dystonia. Ann. Neurol. 2004, 56:541-547.
38. Mikolaenko I., et al. A Golgi study of neuronal architecture in a genetic mouse model for Lesch-Nyhan disease. Neurobiol. Dis. 2005, 20:479-490.
39. Mink J.W. Abnormal circuit function in dystonia. Neurology 2006, 66:959.
40. Nakamura R., et al. An immunohistochemical study of Purkinje cells in a case of hereditary cerebellar cortical atrophy. Acta Neuropathol. 1999, 97:196-200.
41. Neychev V., et al. The basal ganglia and cerebellum interact in the expression of dystonic movement. Brain 2008, 131:2499-2509.
42. Neychev V.K., et al. The functional neuroanatomy of dystonia. Neurobiol. Dis. 2011, 42:185-201.
43. Oleas J., et al. Engineering animal models for dystonia: what have we learned?. Mov. Disord. 2013, 28:990-1000.
44. Ozelius L.J., et al. The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nat. Genet. 1997, 17:408.
45. Paxinos G., Franklin K.B.J. The Mouse Brain in Stereotaxic Coordinates 2001, Academic Press, San Diego.
46. Perlmutter J.S., Mink J.W. Dysfunction of dopaminergic pathways in dystonia. Adv. Neurol. 2004, 94:163-170.
47. Peterson D.A., et al. Convergent evidence for abnormal striatal synaptic plasticity in dystonia. Neurobiol. Dis. 2010, 37:558-573.
48. Pisani A., et al. Altered responses to dopaminergic D2 receptor activation and N-type calcium currents in striatal cholinergic interneurons in a mouse model of DYT1 dystonia. Neurobiol. Dis. 2006, 24:318-325.
49. Pizoli C.E., et al. Abnormal cerebellar signaling induces dystonia in mice. J. Neurosci. 2002, 22:7825-7833.
50. Prudente C.N., et al. Neuropathology of cervical dystonia. Exp. Neurol. 2012, 241:95-104.
51. Puglisi F., et al. Torsin A localization in the mouse cerebellar synaptic circuitry. PLoS One 2013, 8:e6803.
52. Raike R.S., et al. Limited regional cerebellar dysfunction induces focal dystonia in mice. Neurobiol. Dis. 2012, 49:200-210.
53. Rostasy K., et al. TorsinA protein and neuropathology in early onset generalized dystonia with GAG deletion. Neurobiol. Dis. 2003, 12:11-24.
54. Sadnicka A., et al. The cerebellum in dystonia-help or hindrance?. Clin. Neurophysiol. 2012, 123:65-70.
55. Sciamanna G., et al. Cholinergic dysregulation produced by selective inactivation of the dystonia-associated protein torsinA. Neurobiol. Dis. 2012, 47:416-427.
56. Sciamanna G., et al. Cholinergic dysfunction alters synaptic integration between thalamostriatal and corticostriatal inputs in DYT1 dystonia. J. Neurosci. 2012, 32:11991-12004.
57. Shashidharan P., et al. Immunohistochemical localization and distribution of torsinA in normal human and rat brain. Brain Res. 2000, 853:197-206.
58. Shashidharan P., et al. Transgenic mouse model of early-onset dyt1 dystonia. Hum. Mol. Genet. 2005, 14:125-133.
59. Shirley T.L., et al. Paroxysmal dyskinesias in mice. Mov. Disord. 2008, 23:259-264.
60. Song C.H., et al. Functional analysis of dopaminergic systems in a DYT1 knock-in mouse model of dystonia. Neurobiol. Dis. 2012, 48:66-78.
61. Song C.H., et al. Subtle microstructural changes of the striatum in a DYT1 knock-in mouse model of dystonia. Neurobiol. Dis. 2013, 54:362-371.
62. Standaert D.G. Update on the pathology of dystonia. Neurobiol. Dis. 2011, 42:148-151.
63. Tanabe L.M., et al. Primary dystonia: molecules and mechanisms. Nat. Rev. Neurol. 2009, 5:598-609.
64. Ulug A.M., et al. Cerebellothalamocortical pathway abnormalities in torsinA DYT1 knock-in mice. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:6638-6643.
65. Warner T.T., et al. TorsinA and DYT1 dystonia: a synaptopathy?. Biochem. Soc. Trans. 2010, 38:452-456.
66. Wichmann T. Commentary: dopaminergic dysfunction in DYT1 dystonia. Exp. Neurol. 2008, 212:242-246.
67. Xiao J., et al. Developmental expression of rat torsinA transcript and protein. Brain Res. Dev. Brain Res. 2004, 152:47-60.
68. Yamada M., et al. CAG repeat disorder models and human neuropathology: similarities and differences. Acta Neuropathol. 2008, 115:71-86.
69. Zhang L., et al. Altered dendritic morphology of Purkinje cells in Dyt1 DeltaGAG knock-in and purkinje cell-specific Dyt1 conditional knockout mice. PLoS One 2011, 6:e18357.
70. Zhao Y., et al. The DYT1 carrier state increases energy demand in the olivocerebellar network. Neuroscience 2011, 177:183-194.
71. Zoons E., et al. Structural, functional and molecular imaging of the brain in primary focal dystonia-a review. Neuroimage 2011, 56:1011-1020.